开云app官网登录入口网页版-官方正版

#徐兵河#

16篇内容 | 1291人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2130154, encodeId=a7992130154fb, content=中国医学科学院<a href='/topic/show?id=4804503e4d0' target=_blank style='color:#2F92EE;'>#徐兵河#</a>团队发现<a href='/topic/show?id=2a4d391818a' target=_blank style='color:#2F92EE;'>#吡咯替尼#</a>加<a href='/topic/show?id=a82f36493c4' target=_blank style='color:#2F92EE;'>#卡培他滨#</a>可显著提高<a href='/topic/show?id=833e8e39dc' target=_blank style='color:#2F92EE;'>#HER2阳性转移性乳腺癌#</a>的总生存期, objectTitle=STTT | 中国医学科学院徐兵河团队发现吡咯替尼加卡培他滨可显著提高HER2阳性转移性乳腺癌的总生存期, objectType=article, longId=763783, objectId=7163e63783ea, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/health-insurance-PK235DP.jpg, objectUrl=/article/show_article.do?id=7163e63783ea, replyNumber=0, likeNumber=125, createdTime=2023-05-05, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=7163e63783ea, moduleTitle=STTT | 中国医学科学院徐兵河团队发现吡咯替尼加卡培他滨可显著提高HER2阳性转移性乳腺癌的总生存期, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=7163e63783ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1676780, encodeId=b80316e67808e, content=<a href='/topic/show?id=4804503e4d0' target=_blank style='color:#2F92EE;'>#徐兵河#</a>, objectTitle=第八届“首都十大健康卫士”揭榜！童朝晖、徐兵河、郭卫、杜斌、赵扬玉、张罗等上榜, objectType=article, longId=736150, objectId=3ce6e3615024, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ce6e3615024, replyNumber=0, likeNumber=77, createdTime=2023-03-27, rootId=0, userName=wleon8904, userId=539727370645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ce6e3615024, moduleTitle=第八届“首都十大健康卫士”揭榜！童朝晖、徐兵河、郭卫、杜斌、赵扬玉、张罗等上榜, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3ce6e3615024)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1676778, encodeId=bed516e6778a6, content=<a href='/topic/show?id=4804503e4d0' target=_blank style='color:#2F92EE;'>#徐兵河#</a>, objectTitle=BMC Cancer：徐兵河院士团队分析中国汉族人群转移性乳腺癌伴有同时性肺转移患者的临床病理特征和生存预后, objectType=article, longId=292795, objectId=4e9b292e95cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e9b292e95cc, replyNumber=0, likeNumber=86, createdTime=2022-11-11, rootId=0, userName=wleon8904, userId=539727370645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e9b292e95cc, moduleTitle=BMC Cancer：徐兵河院士团队分析中国汉族人群转移性乳腺癌伴有同时性肺转移患者的临床病理特征和生存预后, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=4e9b292e95cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1676779, encodeId=eaf816e677930, content=<a href='/topic/show?id=4804503e4d0' target=_blank style='color:#2F92EE;'>#徐兵河#</a>, objectTitle=Front Oncol：徐兵河院士团队发现HER2-乳腺癌中HER2低表达可能是预后良好指标, objectType=article, longId=294156, objectId=e468294156ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e468294156ec, replyNumber=0, likeNumber=67, createdTime=2022-10-18, rootId=0, userName=wleon8904, userId=539727370645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e468294156ec, moduleTitle=Front Oncol：徐兵河院士团队发现HER2-乳腺癌中HER2低表达可能是预后良好指标, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e468294156ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1676777, encodeId=09f716e67774d, content=<a href='/topic/show?id=4804503e4d0' target=_blank style='color:#2F92EE;'>#徐兵河#</a>, objectTitle=Nature Medicine: 新晋院士徐兵河论文：治疗耐药性晚期乳腺癌的3期临床试验, objectType=article, longId=220854, objectId=1e7b22085476, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e7b22085476, replyNumber=0, likeNumber=98, createdTime=2021-12-13, rootId=0, userName=wleon8904, userId=539727370645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e7b22085476, moduleTitle=Nature Medicine: 新晋院士徐兵河论文：治疗耐药性晚期乳腺癌的3期临床试验, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=1e7b22085476)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1676776, encodeId=033816e6776f1, content=<a href='/topic/show?id=4804503e4d0' target=_blank style='color:#2F92EE;'>#徐兵河#</a>, objectTitle=徐兵河教授：CDK4/6抑制剂在乳腺癌治疗中的价值, objectType=article, longId=151214, objectId=deb21512143c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=deb21512143c, replyNumber=0, likeNumber=100, createdTime=2019-07-25, rootId=0, userName=wleon8904, userId=539727370645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=deb21512143c, moduleTitle=徐兵河教授：CDK4/6抑制剂在乳腺癌治疗中的价值, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=deb21512143c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1676775, encodeId=1a5f16e677504, content=<a href='/topic/show?id=4804503e4d0' target=_blank style='color:#2F92EE;'>#徐兵河#</a>, objectTitle=徐兵河教授：Foundation One®在晚期乳腺癌中的应用, objectType=article, longId=141059, objectId=87f1141059af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87f1141059af, replyNumber=0, likeNumber=72, createdTime=2018-08-04, rootId=0, userName=wleon8904, userId=539727370645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87f1141059af, moduleTitle=徐兵河教授：Foundation One®在晚期乳腺癌中的应用, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=87f1141059af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1676774, encodeId=403d16e6774d6, content=<a href='/topic/show?id=4804503e4d0' target=_blank style='color:#2F92EE;'>#徐兵河#</a>, objectTitle=徐兵河教授：泛ErbB受体TKI吡咯替尼具有治疗晚期乳腺癌潜力, objectType=article, longId=123407, objectId=3bce12340e38, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3bce12340e38, replyNumber=0, likeNumber=91, createdTime=2018-06-14, rootId=0, userName=wleon8904, userId=539727370645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3bce12340e38, moduleTitle=徐兵河教授：泛ErbB受体TKI吡咯替尼具有治疗晚期乳腺癌潜力, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3bce12340e38)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1676770, encodeId=69ac16e677090, content=<a href='/topic/show?id=4804503e4d0' target=_blank style='color:#2F92EE;'>#徐兵河#</a>, objectTitle=徐兵河教授：晚期乳腺癌ABC4共识更新要点, objectType=article, longId=119211, objectId=13cc11921112, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13cc11921112, replyNumber=0, likeNumber=82, createdTime=2018-01-01, rootId=0, userName=wleon8904, userId=539727370645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13cc11921112, moduleTitle=徐兵河教授：晚期乳腺癌ABC4共识更新要点, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=13cc11921112)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1676772, encodeId=7eaa16e6772a9, content=<a href='/topic/show?id=4804503e4d0' target=_blank style='color:#2F92EE;'>#徐兵河#</a>, objectTitle=【CSCO 2017】徐兵河教授呼吁对乳腺癌患者进行全程全方位管理, objectType=article, longId=120335, objectId=041d120335f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=041d120335f1, replyNumber=0, likeNumber=74, createdTime=2018-09-20, rootId=0, userName=wleon8904, userId=539727370645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=041d120335f1, moduleTitle=【CSCO 2017】徐兵河教授呼吁对乳腺癌患者进行全程全方位管理, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=041d120335f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1676773, encodeId=532f16e6773a9, content=<a href='/topic/show?id=4804503e4d0' target=_blank style='color:#2F92EE;'>#徐兵河#</a>, objectTitle=2017 SABCS中国之最！徐兵河教授团队4项研究入围, objectType=article, longId=122843, objectId=03b7122843b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=03b7122843b1, replyNumber=0, likeNumber=80, createdTime=2018-11-14, rootId=0, userName=wleon8904, userId=539727370645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=03b7122843b1, moduleTitle=2017 SABCS中国之最！徐兵河教授团队4项研究入围, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=03b7122843b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1676769, encodeId=599e16e676982, content=<a href='/topic/show?id=4804503e4d0' target=_blank style='color:#2F92EE;'>#徐兵河#</a>, objectTitle=徐兵河教授：早期乳腺癌辅助治疗中的加减法策略, objectType=article, longId=117199, objectId=e3d711e19963, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3d711e19963, replyNumber=0, likeNumber=74, createdTime=2018-09-03, rootId=0, userName=wleon8904, userId=539727370645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3d711e19963, moduleTitle=徐兵河教授：早期乳腺癌辅助治疗中的加减法策略, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e3d711e19963)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1676771, encodeId=34a816e6771db, content=<a href='/topic/show?id=4804503e4d0' target=_blank style='color:#2F92EE;'>#徐兵河#</a>, objectTitle=[ABC4]徐兵河教授：HER2阳性晚期乳腺癌治疗的“变”与“不变”, objectType=article, longId=119222, objectId=de27119222d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de27119222d0, replyNumber=0, likeNumber=82, createdTime=2018-09-04, rootId=0, userName=wleon8904, userId=539727370645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de27119222d0, moduleTitle=[ABC4]徐兵河教授：HER2阳性晚期乳腺癌治疗的“变”与“不变”, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=de27119222d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1676768, encodeId=e27c16e6768a5, content=<a href='/topic/show?id=4804503e4d0' target=_blank style='color:#2F92EE;'>#徐兵河#</a>, objectTitle=徐兵河：乳腺癌诊疗须坚持个体化, objectType=article, longId=75677, objectId=8467e567779, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8467e567779, replyNumber=0, likeNumber=133, createdTime=2017-06-28, rootId=0, userName=wleon8904, userId=539727370645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8467e567779, moduleTitle=徐兵河：乳腺癌诊疗须坚持个体化, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=8467e567779)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1676767, encodeId=029816e6767ad, content=<a href='/topic/show?id=4804503e4d0' target=_blank style='color:#2F92EE;'>#徐兵河#</a>, objectTitle=回忆姚贝娜抗癌历程，领会徐兵河专业解说，学习乳腺癌预防策略, objectType=article, longId=45656, objectId=36be45656ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36be45656ea, replyNumber=0, likeNumber=90, createdTime=2015-09-03, rootId=0, userName=wleon8904, userId=539727370645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36be45656ea, moduleTitle=回忆姚贝娜抗癌历程，领会徐兵河专业解说，学习乳腺癌预防策略, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=36be45656ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1676766, encodeId=fdd316e6766df, content=<a href='/topic/show?id=4804503e4d0' target=_blank style='color:#2F92EE;'>#徐兵河#</a>, objectTitle=ASCO 2014：徐兵河教授对话ASCO主席Clifford Hudis教授谈乳腺癌研究50年, objectType=article, longId=35979, objectId=d829359e93c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d829359e93c, replyNumber=0, likeNumber=84, createdTime=2014-10-18, rootId=0, userName=wleon8904, userId=539727370645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d829359e93c, moduleTitle=ASCO 2014：徐兵河教授对话ASCO主席Clifford Hudis教授谈乳腺癌研究50年, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d829359e93c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

徐兵河

2020-05-29

侠胆医心 (审核中...)

前往app查看评论内容

中国医学科学院#徐兵河#团队发现#吡咯替尼#加#卡培他滨#可显著提高#HER2阳性转移性乳腺癌#的总生存期

STTT | 中国医学科学院徐兵河团队发现吡咯替尼加卡培他滨可显著提高HER2阳性转移性乳腺癌的总生存期

2023-05-05发表于上海

wleon8904 (审核中...)

前往app查看评论内容

#徐兵河#

第八届“首都十大健康卫士”揭榜！童朝晖、徐兵河、郭卫、杜斌、赵扬玉、张罗等上榜

2023-03-27

wleon8904 (审核中...)

前往app查看评论内容

#徐兵河#

BMC Cancer：徐兵河院士团队分析中国汉族人群转移性乳腺癌伴有同时性肺转移患者的临床病理特征和生存预后

2022-11-11

wleon8904 (审核中...)

前往app查看评论内容

#徐兵河#

Front Oncol：徐兵河院士团队发现HER2-乳腺癌中HER2低表达可能是预后良好指标

2022-10-18

wleon8904 (审核中...)

前往app查看评论内容

#徐兵河#

Nature Medicine: 新晋院士徐兵河论文：治疗耐药性晚期乳腺癌的3期临床试验

2021-12-13

wleon8904 (审核中...)

前往app查看评论内容

#徐兵河#

徐兵河教授：CDK4/6抑制剂在乳腺癌治疗中的价值

2019-07-25

wleon8904 (审核中...)

前往app查看评论内容

#徐兵河#

徐兵河教授：Foundation One®在晚期乳腺癌中的应用

2018-08-04

wleon8904 (审核中...)

前往app查看评论内容

#徐兵河#

徐兵河教授：泛ErbB受体TKI吡咯替尼具有治疗晚期乳腺癌潜力

2018-06-14

wleon8904 (审核中...)

前往app查看评论内容

#徐兵河#

徐兵河教授：晚期乳腺癌ABC4共识更新要点

2018-01-01

wleon8904 (审核中...)

前往app查看评论内容

#徐兵河#

【CSCO 2017】徐兵河教授呼吁对乳腺癌患者进行全程全方位管理

2018-09-20

wleon8904 (审核中...)

前往app查看评论内容

#徐兵河#

2017 SABCS中国之最！徐兵河教授团队4项研究入围

2018-11-14

wleon8904 (审核中...)

前往app查看评论内容

#徐兵河#

徐兵河教授：早期乳腺癌辅助治疗中的加减法策略

2018-09-03

wleon8904 (审核中...)

前往app查看评论内容

#徐兵河#

[ABC4]徐兵河教授：HER2阳性晚期乳腺癌治疗的“变”与“不变”

2018-09-04

wleon8904 (审核中...)

前往app查看评论内容

#徐兵河#

徐兵河：乳腺癌诊疗须坚持个体化

2017-06-28

wleon8904 (审核中...)

前往app查看评论内容

#徐兵河#

回忆姚贝娜抗癌历程，领会徐兵河专业解说，学习乳腺癌预防策略

2015-09-03

wleon8904 (审核中...)

前往app查看评论内容

#徐兵河#

ASCO 2014：徐兵河教授对话ASCO主席Clifford Hudis教授谈乳腺癌研究50年

2014-10-18

科室
- - 订阅+
  - 更多科室
工具
服务